{"id":2950,"date":"2023-03-31T11:17:48","date_gmt":"2023-03-31T09:17:48","guid":{"rendered":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/?p=2950"},"modified":"2023-07-10T20:04:25","modified_gmt":"2023-07-10T18:04:25","slug":"elindult-a-neohterma-vizsgalat","status":"publish","type":"post","link":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/2023\/03\/31\/elindult-a-neohterma-vizsgalat\/","title":{"rendered":"NeoHTerMa klinikai vizsg\u00e1lat indult"},"content":{"rendered":"<p style=\"text-align: justify\">Prof. Dr. Dank Magdolna vezet\u00e9s\u00e9vel elindult a NeoHTerMa klinikai vizsg\u00e1lat, mely sor\u00e1n az Oncotherm EHY-2030 k\u00e9sz\u00fcl\u00e9kkel alkalmazott konkomitt\u00e1ns modul\u00e1lt elektrohypertermia (mEHT) kezel\u00e9sek hat\u00e9konys\u00e1g\u00e1t vizsg\u00e1ljuk a kedvez\u0151tlen progn\u00f3zis\u00fa HER2-negat\u00edv eml\u0151tumorokban.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2951 size-large\" title=\"Owner: Oncotherm Kft.\" src=\"https:\/\/semmelweis.hu\/onkologiai-kozpont\/files\/2023\/06\/dds_6565-original_onco_logo-1024x570.png\" alt=\"\" width=\"690\" height=\"384\" srcset=\"https:\/\/semmelweis.hu\/onkologiai-kozpont\/files\/2023\/06\/dds_6565-original_onco_logo-1024x570.png 1024w, https:\/\/semmelweis.hu\/onkologiai-kozpont\/files\/2023\/06\/dds_6565-original_onco_logo-400x223.png 400w, https:\/\/semmelweis.hu\/onkologiai-kozpont\/files\/2023\/06\/dds_6565-original_onco_logo-768x428.png 768w, https:\/\/semmelweis.hu\/onkologiai-kozpont\/files\/2023\/06\/dds_6565-original_onco_logo-539x300.png 539w, https:\/\/semmelweis.hu\/onkologiai-kozpont\/files\/2023\/06\/dds_6565-original_onco_logo-1536x855.png 1536w, https:\/\/semmelweis.hu\/onkologiai-kozpont\/files\/2023\/06\/dds_6565-original_onco_logo-2048x1140.png 2048w\" sizes=\"auto, (max-width: 690px) 100vw, 690px\" \/><\/p>\n<p style=\"text-align: justify\">A vizsg\u00e1lat c\u00e9lja megvizsg\u00e1lni, hogy a 2 cm-n\u00e9l nagyobb \u00e9s\/vagy axill\u00e1ris nyirokcsom\u00f3\u00e1tt\u00e9ttel rendelkez\u0151 HER2-negat\u00edv eml\u0151tumorok &#8211; melyek az \u00f6sztrog\u00e9n \u00e9s\/vagy hormonreceptor pozit\u00edv, \u00e9s a tripla-negat\u00edv (TNBC) eml\u0151tumorok &#8211; eset\u00e9n a neoadjuv\u00e1ns kezel\u00e9sk\u00e9nt alkalmazott heti paclitaxel (TNBC betegekn\u00e9l carboplatinnal kieg\u00e9sz\u00edtve) + AC prtokoll mellett a mEHT ter\u00e1pia jelent\u0151sen jav\u00edtja-e a betegs\u00e9g klinikai kimenetel\u00e9t \u00e9s az optim\u00e1lis seb\u00e9szeti st\u00e1tusz el\u00e9r\u00e9s\u00e9t, az \u00f6nmag\u00e1ban alkalmazott kemoter\u00e1pi\u00e1val \u00f6sszehasonl\u00edtva.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prof. Dr. Dank Magdolna vezet\u00e9s\u00e9vel elindult a NeoHTerMa klinikai vizsg\u00e1lat, mely sor\u00e1n az Oncotherm EHY-2030 k\u00e9sz\u00fcl\u00e9kkel alkalmazott konkomitt\u00e1ns modul\u00e1lt elektrohypertermia (mEHT) kezel\u00e9sek hat\u00e9konys\u00e1g\u00e1t vizsg\u00e1ljuk a kedvez\u0151tlen progn\u00f3zis\u00fa HER2-negat\u00edv eml\u0151tumorokban. A vizsg\u00e1lat c\u00e9lja megvizsg\u00e1lni, hogy a 2 cm-n\u00e9l nagyobb \u00e9s\/vagy axill\u00e1ris nyirokcsom\u00f3\u00e1tt\u00e9ttel rendelkez\u0151 HER2-negat\u00edv eml\u0151tumorok &#8211; melyek az \u00f6sztrog\u00e9n \u00e9s\/vagy hormonreceptor pozit\u00edv, \u00e9s a tripla-negat\u00edv (TNBC) &hellip;<\/p>\n","protected":false},"author":102054,"featured_media":2951,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2950","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hirek"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/posts\/2950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/users\/102054"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/comments?post=2950"}],"version-history":[{"count":5,"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/posts\/2950\/revisions"}],"predecessor-version":[{"id":3202,"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/posts\/2950\/revisions\/3202"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/media\/2951"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/media?parent=2950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/categories?post=2950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/onkologiai-kozpont\/wp-json\/wp\/v2\/tags?post=2950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}